Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clicking Larynx Syndrome: When the Hyoid Bone and Thyroid Cartilage Collide.

Deutsches Arzteblatt international·2026
Same author

Stiffness and Tissue Viscosity in a Cerebral Neoplasm Measured by Preoperative Multifrequency Magnetic Resonance Elastography (MRE) Guide the Differential Diagnosis of Brain Tumors by Ruling Out Glioma.

Case reports in medicine·2026
Same author

Correction: How pain intensity and mental disorders shape chronic pain sick leave and quality of life in the general Spanish population.

Scientific reports·2026
Same author

Clinical Spectrum of Anti-SEZ6L2 Syndrome: A Case Report With Brain Volumetry and Systematic Literature Review.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Hyperbaric oxygen therapy improves clinical symptoms and functional capacity and modulates thalamic connectivity in ME/CFS: a prospective cohort study.

Journal of translational medicine·2026
Same author

Replication and compartmentalization of Dobrava-Belgrade virus in the central nervous system.

Emerging microbes & infections·2026
Same journal

Clinical response after cerebrospinal fluid shunting in complex versus pure idiopathic normal pressure hydrocephalus: A systematic review and meta-analysis.

Clinical neurology and neurosurgery·2026
Same journal

Preoperative sleep medication use and outcomes following lumbar spine surgery.

Clinical neurology and neurosurgery·2026
Same journal

Long-term real-world outcomes and device management of intrathecal drug delivery systems: A 16-year single-center experience with a primary focus on baclofen therapy.

Clinical neurology and neurosurgery·2026
Same journal

Trends and safety of outpatient versus inpatient lumbar interbody fusion - A national cohort study.

Clinical neurology and neurosurgery·2026
Same journal

A case report on αIN antibody-mediated paraneoplastic cerebellar ataxia.

Clinical neurology and neurosurgery·2026
Same journal

Early prediction of prolonged mechanical ventilation in invasively ventilated patients with subarachnoid hemorrhage: A MIMIC-IV prediction model study.

Clinical neurology and neurosurgery·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Multiple system atrophy masking multiple sclerosis.

Carsten Finke1, Eberhard Siebert, Michail Plotkin

  • 1Department of Neurology, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, D-10117 Berlin, Germany. carsten.finke@charite.de

Clinical Neurology and Neurosurgery
|September 9, 2009
PubMed
Summary
This summary is machine-generated.

This case report details a rare instance of simultaneous Multiple System Atrophy (MSA) and Multiple Sclerosis (MS) in one patient. MSA symptoms delayed MS diagnosis and treatment, highlighting diagnostic challenges.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Related Experiment Videos

Last Updated: Jun 20, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Autoimmune Disorders

Background:

  • Multiple system atrophy (MSA) and multiple sclerosis (MS) are distinct progressive neurological disorders.
  • While both conditions present with overlapping symptoms, they are rarely considered together in differential diagnoses due to differing disease courses and onset ages.

Observation:

  • A unique case of a single patient diagnosed with both MSA and MS is presented.
  • The patient's clinical presentation was predominantly characterized by MSA, which obscured the diagnosis of MS.
  • This led to a delay in the diagnosis and initiation of treatment for multiple sclerosis.

Findings:

  • The study analyzes the specific clinical symptoms observed in the patient.
  • Key features distinguishing MSA from MS in this complex presentation are highlighted.
  • The report emphasizes the diagnostic challenges posed by the co-occurrence of these two neurological conditions.

Implications:

  • This case underscores the importance of considering rare co-diagnoses in neurology.
  • It highlights the need for careful clinical evaluation to differentiate overlapping neurological disorders.
  • Understanding these differentiating features can improve diagnostic accuracy and patient management for complex neurological cases.